IRIS
RUGGERI, Rosaria Maddalena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 18.896
NA - Nord America 11.126
AS - Asia 6.744
SA - Sud America 2.350
AF - Africa 233
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 14
Totale 39.381
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.877
RU - Federazione Russa 7.129
IT - Italia 6.006
SG - Singapore 2.747
BR - Brasile 1.998
CN - Cina 1.892
IE - Irlanda 1.528
SE - Svezia 1.323
HK - Hong Kong 731
DE - Germania 610
FR - Francia 561
VN - Vietnam 426
NL - Olanda 353
UA - Ucraina 343
FI - Finlandia 333
GB - Regno Unito 289
IN - India 247
BD - Bangladesh 139
AR - Argentina 128
CA - Canada 122
PL - Polonia 101
TR - Turchia 78
IQ - Iraq 71
ZA - Sudafrica 71
MX - Messico 70
EC - Ecuador 56
CO - Colombia 52
AT - Austria 51
CZ - Repubblica Ceca 51
JP - Giappone 48
BE - Belgio 45
ID - Indonesia 43
MA - Marocco 43
PK - Pakistan 43
UZ - Uzbekistan 42
VE - Venezuela 33
ES - Italia 31
SA - Arabia Saudita 29
CH - Svizzera 27
CL - Cile 26
TN - Tunisia 25
CI - Costa d'Avorio 24
AE - Emirati Arabi Uniti 18
IR - Iran 18
PE - Perù 18
KE - Kenya 17
LT - Lituania 17
AZ - Azerbaigian 16
DZ - Algeria 16
EG - Egitto 15
MY - Malesia 15
PY - Paraguay 15
KZ - Kazakistan 14
PH - Filippine 14
DO - Repubblica Dominicana 13
AL - Albania 12
AU - Australia 12
IL - Israele 12
JO - Giordania 12
UY - Uruguay 11
JM - Giamaica 10
RS - Serbia 10
BG - Bulgaria 9
BO - Bolivia 9
CR - Costa Rica 9
NP - Nepal 9
PS - Palestinian Territory 9
DK - Danimarca 8
EU - Europa 8
LB - Libano 8
PT - Portogallo 8
RO - Romania 8
KG - Kirghizistan 7
BY - Bielorussia 6
GE - Georgia 6
GR - Grecia 6
HU - Ungheria 6
LV - Lettonia 6
OM - Oman 6
SN - Senegal 6
XK - ???statistics.table.value.countryCode.XK??? 6
AM - Armenia 5
PA - Panama 5
SY - Repubblica araba siriana 5
GT - Guatemala 4
HN - Honduras 4
KR - Corea 4
LK - Sri Lanka 4
NG - Nigeria 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
TH - Thailandia 4
ET - Etiopia 3
KW - Kuwait 3
MD - Moldavia 3
MM - Myanmar 3
SR - Suriname 3
TT - Trinidad e Tobago 3
AO - Angola 2
BB - Barbados 2
Totale 39.336
Salva come PNG Salva come JPEG
Città #
Moscow 1.947
Ashburn 1.720
Dublin 1.522
Singapore 1.502
Dallas 1.243
Chandler 1.207
Hong Kong 728
Nyköping 700
Jacksonville 687
Beijing 685
San Jose 582
Milan 528
Rome 462
Messina 362
The Dalles 355
Los Angeles 264
Princeton 261
Lauterbourg 246
Dearborn 244
New York 227
Medford 226
Cambridge 203
Naples 199
Munich 187
Des Moines 184
Ann Arbor 162
São Paulo 149
Ho Chi Minh City 130
Buffalo 119
Council Bluffs 118
Turin 117
Boardman 106
Bologna 99
Catania 94
Bremen 93
Bari 89
Palermo 85
Jinan 78
Hanoi 77
Tianjin 77
Warsaw 76
Redondo Beach 75
Turku 75
Florence 74
Wilmington 73
Guangzhou 71
Lancaster 65
Santa Clara 64
Pune 61
Genoa 60
Helsinki 60
Dong Ket 58
Hyderabad 58
Nanjing 57
San Mateo 57
Frankfurt am Main 56
Woodbridge 54
Rio de Janeiro 51
Orem 50
Shenyang 50
Brasília 44
Brooklyn 43
Brussels 43
Belo Horizonte 42
Houston 42
Tokyo 42
Johannesburg 41
Denver 40
Seattle 38
Montreal 37
Vienna 36
Zhengzhou 36
Brescia 35
Tashkent 35
London 34
San Francisco 34
Porto Alegre 33
Chennai 31
Shenzhen 31
Hebei 29
Parma 29
Trieste 29
Modena 28
Ningbo 28
Verona 28
Cagliari 27
Haikou 27
Nuremberg 27
Shanghai 27
Brno 26
Hangzhou 25
Abidjan 24
Baghdad 24
Chicago 24
Pisa 24
Salvador 24
Stockholm 24
Taizhou 24
Curitiba 23
Monza 23
Totale 20.570
Salva come PNG Salva come JPEG
Nome #
LA LOCALIZZAZIONE ISTMICA DEL NODULO TIROIDEO MALIGNO RAPPRESENTA UN FATTORE ADDIZIONALE DI RISCHIO PER METASTASI IN PAZIENTI AFFETTI DA CARCINOMA DIFFERENZIATO DELLA TIROIDE (CDT) A BASSO RISCHIO 4.650
I LIVELLI SIERICI DI INTERLEUCHINA 23 (IL-23) SONO AUMENTATI NEI PAZIENTI CON TIROIDITE DI HASHIMOTO (TH) DI NUOVA DIAGNOSI RISPETTO AI CONTROLLI SANI 727
EMIAGENESIA TIROIDEA, MORBO DI BASEDOW-GRAVES E CARCINOMA DIFFERENZIATO DELLA TIROIDE: UN’ASSOCIAZIONE MOLTO RARA. 326
IL GRADO DI COINVOLGIMENTO CUTANEO, VALUTATO COME SKIN SCORE SECONDO RODNAN, NEI PAZIENTI CON SCLEROSI SISTEMICA (SS) CORRELA CON I LIVELLI SIERICI DI TSH 323
99mTc-Methoxy-Isobutyl-Isonitrile Scintigraphy Is a Useful Tool for Assessing the Risk of Malignancy in Thyroid Nodules with Indeterminate Fine-Needle Cytology 276
131I RADIOIODINE THERAPY (RIT) OF HYPERTYROIDISM DUE TO GRAVES’ DISEASE (GD) OR UNI-MULTINODULAR TOXIC GOITER (NTG): OUR EXPERIENCE 257
131I Radioiodine therapy (RIT) of hyperthyroidism due to Graves' disease (GD) or uni-multinodular toxic goiter (NTG): our experience 247
I livelli sierici di interleuchina 22 (IL-22) sono aumentati nella tiroidite di Hashimoto rispetto alle tireopatie non autoimmuni ed ai controlli sani. 209
ACCIDENTAL DISCOVERY OF LUNG METATSTASES FROM DIFFERENTIATED THYROID CANCER BY TC-99M PERTECHNETATE SCAN IN A PATIENT WITH SECONDARY HYPERPARATHYROIDISM 208
Cardiovascular events in acromegaly: distinct role of Agatston and Framingham score in the 5-year prediction. 204
Expression of P53 and isoforms in bening and malignant lesions of the head and neck 203
Abnormal 99mTc-MIBI Uptakein left lung mimicking a neoplastic lesion in a young woman with nodular goiter. A rare pitfall of 99mTc-MIBI 200
An analytical model for improving absorbed dose calculation accuracy in non spherical autonomous functioning thyroid nodule 196
Abnormal radioiodine uptake on post-therapy whole body scan and sodium/iodine symporter expression in a dermoid cyst of the ovary: report of a case and review of the literature 195
Cell proliferation parameters and apoptosis indices in pituitary macroadenomas 194
Immunoreactions for P53 isoforms are associated with ultrastructural proliferative profiles in benign thyroid nodules 194
AN UNUSUAL CASE OF MARINE-LENHART SYNDROME. 193
99mTc-Methoxy-Isobutil-Isonitrile (MIBI) scintigraphy is an useful and cost-effective tool for assessing the risk of malignancy in thyroid nodules with indeterminate fine needle cytology (FNAC) 191
Association of parathyroid carcinoma and thyroid disorders: A clinical review 191
Association of autonously functioning ("hot") thyroid nodules with Hashimotos' thyroiditis (HT). 190
Clinico-pathological significance of cell-type-specific loss of heterozygosity on chromosome 7q21: analysis of 318 microdissected thyroid lesions 186
Un caso di orticaria cronica idiopatica (OCI) associata a morbo di Basedow (MB): tipizzazione HLA. 185
Allelic loss at 7q21 is a frequent and early event in thyroid follicular tumors. 184
Accidental discovery of lung metastases from differentiated thyroid cancer by 99mTc sodium pertechnetate scan in a patient with secondary hyperparathyroidism 183
Abnormal radioiodine uptake in an abdominal dermoid cyst in a patient affected by differentiated thyroid cancer 183
Hyaluronan oligosaccharides induce inflammatory response in human thyrocytes cultures by affecting Toll-like receptors 183
BRAFV600Emutation is associated with increased prevalence of contralateral lymph-node metastases in low and low-to-intermediate risk papillary thyroid cancer 183
AUMENTATO STRESS OSSIDATIVO NELLA TIROIDITE DI HASHIMOTO (TH) CON EUTIROIDISMO 182
Hyperthyroidism treatment with calculated activity of 131-Radioiodine: our experience 181
ACCUMULO DI TECNEZIO IN METASTASI POLMONARI DA CARCINOMA DIFFERENZIATO TIROIDEO (CDT): UNA RARA EVENIENZA 181
Central nervous system vasculitis after starting methimazole in a woman with Graves' disease 181
Analisi immunoistochimica dei "pathways" del sistema HGF/c-met in noduli tiroidei benigni e maligni. 179
Co-expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) in thyroid nodules is associated with co-expression of CD30 ligand/CD30 receptor 178
CD30 and CD30 ligand (CD30L) expression in decidual samples of spontaneous abortions. 178
Is malignant nodule topography an additional risk factor for metastatic disease in low-risk differentiated thyroid cancer? 178
HER2 analysis in sporadic thyroid cancer of follicular cell origin 177
Analisi immunoistochimica dell'espressione dlel'epidermal growth factor receptor (EGFR) e di HER2 nel carcinoma midollare della tiroide (MCT). 176
Early preablation rhTSH-stimulated thyroglobulin predicts outcome of differentiated thyroid cancer (DTC) patients 175
Radiometabolic therapy with 131I for the ablation of the thyroid remnant in patients affected by differentiated thyroid cancer: comparison between four different activities 173
I livelli sierici di Interleuchina 37 (IL-37) sono aumentati nella Tiroidite di Hashimoto (TH) e correlano con i marcatori di stress ossidativo 173
Braf V600E and 99m-TC MIBI scintigraphy are usefull diagnostic tools in identifying metastatic differentiated thyroid cancer patients refractory to radioiodine therapy. 172
Can the position of malignant thyroid nodule be considered as additional risk factor for recurrent and/or metastatic disease in patients affected by low risk differentiated thyroid cancer? 171
Combined BRAFV600Eanalysis and99mTc-MIBI scintigraphy can be a useful diagnostic tool in differentiated thyroid cancer patients with incomplete bio-chemical response to first radioiodine therapy (RAIT): a pilot investigation 171
Parathyroid carcinoma presenting as normocalcemic hyperparathyroidism 170
Dioxin-like pentachlorobiphenyls promote extra-cellular matrix remodeling by increasing the expression of endothelial cell-specific molecule 1 and metalloproteinases, and induce epigenetic modifications in thyrocytes 169
Thyroid remnant ablation in differentiated thyroid cancer: searching for the most effective radioiodine activity and stimulation strategy ina real life scenario 169
Oxidative stress as a key feature of autoimmune thyroiditis: an update 169
Association of primary hyperparathyroidism (p-hyperPTH) with nodular toxic goiter (NTG) 168
Increased serum interleukin-22 levels in patients with PRL-secreting and non-functioning pituitary macroadenomas. 168
Aplotipi del microsatellite D7S6440, localizzato nell'introne 9 del gene HIPK2, come marcatori molecolari della tiroidite di Hashimoto 168
Adverse childhood experiences and negative emotional responses : risk factors for thyroid autoimmune diseases? 167
Differentiating malignant from benign thyroid nodules with indeterminate cytology by 99mTc-MIBI scan: A new quantitative method for improving diagnostic accuracy 166
Alemtuzumab-induced thyroid events in multiple sclerosis: a systematic review and meta-analysis 166
Oxidative Stress and Advanced Glycation End Products in Hashimoto's Thyroiditis 165
Malattie della Tiroide-Note di anatomia e fisiologia 164
Association of autonomously functioning thyroid nodules (AFTNs) with Hashimoto's thyroiditis (HT) 164
Hyaluronan oligosaccharides modulate inflammatory response, NIS and thyreoglobulin expression in human thyrocytes 164
Clinical usefulness of 99mTc-MIBI scintigraphy in the postsurgical evaluation of patients with differentiated thyroid cancer 164
Increased frequency of the rs2066853 variant of aryl hydrocarbon receptor gene in patients with acromegaly 162
Coexistence of diffuse large B-cell lymphoma and papillary thyroid carcinoma in a patient affected by hashimoto's thyroiditis 162
ATYPICAL PRESENTATION OF PARATHYROID CARCINOMA (PC): REPORT OF TWO CASES 160
Could AGE/RAGE-related oxidative homeostasis dysregulation enhance susceptibility to pathogenesis of cardio-metabolic complications in childhood obesity? 160
Follicular variant of papillary thyroid carcinoma presenting as toxic nodule in an adolescent: coexistent polymorphism of the TSHR and Gsα genes 159
Autoimmune comorbidities in Hashimoto's thyroiditis: different patterns of association in adulthood and childhood/adolescence 159
FOLLICULAR VARIANT OF PAPILLARY THYROID CARCINOMA PRESENTING AS A TOXIC NODULE IN AN ADOLESCENT GIRL 158
Hyperthyroidism treatment with calculated activity of 131–radioiodine 158
Predictive markers of recurrence in radically resected pituitary macroadenomas 157
ASSOCIATION OF PRIMARY HYPERPARATHYROIDISM (P-HYPERPTH) WITH NODULAR TOXIC GOITER (NTG): A PROSPECTIVE STUDY AT AN OUTPATIENT OSTEOPOROSIS SERVICE 157
An uncommon case of Marine-Lenhart syndrome 157
Correlation of cardio-metabolic parameters with vitamin D status in healthy premenopausal women 157
Iodine-131 treatment of hyperthyroidism: our experience 155
Can the position of malignant thyroid nodule be considered as additional risk factor for recurrent and/or metastatic disease in patients affected by low-risk differentiated thyroid cancer? 155
Expressions of Δ 133 isoforms of P53 in multinodular thyroids: the immunoreactions in benign lesions are correlating with subcellular phenotypes of electron microscopy 155
HGF/c-met system targeting PI3K/AKT and STAT3/phosphorylated-STAT3 pathways in pituitary adenomas: an immunohistochemical characterization in view of targeted therapies. 155
Cell-specific loss of heterozygosity (LOH) on chromosome 7q21 in thyroid tumors: analysis on 267 laser capture microdissected thyroid lesions 153
Associazione tra noduli tiroidei iperfunzionanti (noduli "caldi") e tiroidite di Hashimoto 153
Association of primary hyperparathyroidism (p-hyperPTH) with nodular toxic goiter (NTG): a prospective study at an outpatient osteoporosis service 153
Association of autonomously functioning thyroid nodules with Hashimoto’s thyroiditis: study on a large series of patients 153
I livelli sierici del recettore solubile per i prodotti avanzati di glicazione sono ridotti in pazienti pediatrici con tiroidite di Hashimoto 153
Isthmus topography is a risk factor for persistent disease in patients with differentiated thyroid cancer 153
BRAFV600E and 99mTc-MIBI scintigraphy are usefull diagnostic tools in identifying metastatic differentiated thyroid cancer patients refractory to radioiodine therapy 151
Expression of CD30 ligand and CD30 receptor in normal thyroid and benign and malignant thyroid nodules 150
Supra-Acetabular Brown Tumor due to Primary Hyperparathyroidism Associated with Chronic Renal Failure 150
MicroRNAs expression in pituitary tumors: differences related to functional status, pathological features, and clinical behavior 150
BRAF and RAS mutations in differentiated thyroid cancer of patients with low-risk to intermediate-risk treated with radioiodine therapy 150
La paratiroidectomia radioguidata 149
Comparing radioiodine abdominal absorbed dose in differentiated thyroid cancer patients undergone thyroid remnant ablation in either levo-thyroxine withdrawal or after rhtsh stimulation 149
Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective 149
IODINE-131 TREATMENT OF HYPERTHYROIDISM:OUR EXPERIENCE. 147
ATYPICAL PRESENTATION OF PARATHYROID CARCINOMA (PC): REPORT OF TWO CASES 147
Effetto proinfiammatorio degli oligosaccaridi dell'acido ialuronico in tireociti e fibroblasti umani: ruolo dei recettori tool-like di tipo 2(TLR-2) e 4(TLR-4) 147
Hyaluronan oligosaccharides down-regulate NIS and thyroglobulin expression in human thyrocytes 147
Association of autonomously functioning ("hot") thyroid nodules with Hashimoto's thyroiditis 146
Importanza del campionamento precoce del TSH, basale e stimolato dal TRH, nell'ipotiroidismo subclinico 144
Hepatocyte growth factor/C-met axis in thyroid cancer: From diagnostic biomarker to therapeutic target 143
Cystic Fibrosis as a Cause of Malabsorption and Increased Requirement of Levothyroxine 143
un caso di carcinoma delle paratiroidi associato ad adenoma autonomo omolaterale della tiroide 142
Endocrine and metabolic adverse effects of immune checkpoint inhibitors: an overview (what endocrinologists should know) 142
Effects of GH replacement therapy on thyroid volume and nodule development in GH deficient adults: a retrospective cohort study 141
Comment on “Prevalence of undifferentiated inflammatory arthropathy in patients with Hashimoto's thyroiditis in an endocrinology clinic” by Luis M. Valderrama-Hinds and co-workers. Int J Rheum Dis 2019; 22: 1985-1989 141
Totale 22.360
Salva come PNG Salva come JPEG
Categoria #
all - tutte 119.322
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 119.322
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021119 0 0 0 0 0 0 0 0 0 0 0 119
2021/20221.861 25 215 43 105 77 29 101 95 38 299 247 587
2022/20234.804 362 431 232 340 384 534 78 273 1.863 45 178 84
2023/20242.547 111 189 168 216 179 425 121 182 102 271 199 384
2024/20258.349 298 240 372 619 586 404 381 1.521 1.569 587 685 1.087
2025/202617.927 999 1.265 1.273 1.104 1.481 3.585 2.111 2.161 2.356 881 380 331
Totale 39.934